VIA
AMRX icon

Virtus Investment Advisers’s Amneal Pharmaceuticals AMRX Stock Holding History

Virtus Investment Advisers’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,510
Closed -$273K – 487
2024
Q4 		$273K Hold
34,510
– – 0.21% 152
2024
Q3 		$287K Hold
34,510
– – 0.23% 146
2024
Q2 		$219K Hold
34,510
– – 0.19% 172
2024
Q1 		$209K Sell
34,510
-25,200
-42% -$142K 0.15% 188
2023
Q4 		$362K Hold
59,710
– – 0.27% 117
2023
Q3 		$252K Buy
59,710
+15,230
+34% +$56.8K 0.17% 148
2023
Q2 		$138K Hold
44,480
– – 0.09% 220
2023
Q1 		$61.8K Buy
+44,480
New +$88.6K 0.04% 264

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return